Advertisement

Table of Contents

August 20, 2015; 126 (8)

INSIDE BLOOD COMMENTARIES

  • FVIII-VWF dos-à-dos
    Sriram Krishnaswamy
  • Quantitative FDG-PET: a new biomarker in PMBCL
    Michel Meignan
  • Small clots with large impact
    Jan Beyer-Westendorf and Walter Ageno
  • Engineered T cells can fight malignant T cells
    Hans J. Stauss
  • Dicing up T-ALL
    Jon C. Aster
  • New mutation in hairy cell leukemia
    Tadeusz Robak and Piotr Smolewski
  • Cladribine for mastocytosis: benefits and risks
    Cem Akin
  • Platelet GPVI repairs its own damage
    Julie Rayes and Steve P. Watson

PLENARY PAPER

PLENARY PAPER

BLOOD SPOTLIGHT

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

  • Dicer1 imparts essential survival cues in Notch-driven T-ALL via miR-21–mediated tumor suppressor Pdcd4 repression
    Fabian Junker, Antoine Chabloz, Ute Koch and Freddy Radtke
  • Recurrent CDKN1B (p27) mutations in hairy cell leukemia
    Sascha Dietrich, Jennifer Hüllein, Stanley Chun-Wei Lee, Barbara Hutter, David Gonzalez, Sandrine Jayne, Martin J. S. Dyer, Małgorzata Oleś, Monica Else, Xiyang Liu, Mikołaj Słabicki, Bian Wu, Xavier Troussard, Jan Dürig, Mindaugas Andrulis, Claire Dearden, Christof von Kalle, Martin Granzow, Anna Jauch, Stefan Fröhling, Wolfgang Huber, Manja Meggendorfer, Torsten Haferlach, Anthony D. Ho, Daniela Richter, Benedikt Brors, Hanno Glimm, Estella Matutes, Omar Abdel Wahab and Thorsten Zenz

MYELOID NEOPLASIA

  • Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis
    Stéphane Barete, Olivier Lortholary, Gandhi Damaj, Isabelle Hirsch, Marie Olivia Chandesris, Caroline Elie, Mohamed Hamidou, Isabelle Durieu, Felipe Suarez, Bernard Grosbois, Nicolas Limal, Emmanuel Gyan, Claire Larroche, Gérard Guillet, Jean Emmanuel Kahn, Philippe Casassus, Karima Amazzough, Hélène Coignard-Biehler, Sophie Georgin-Lavialle, Ludovic Lhermitte, Sylvie Fraitag, Danielle Canioni, Patrice Dubreuil and Olivier Hermine

PLATELETS AND THROMBOPOIESIS

TRANSPLANTATION

  • Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation
    Laurent Pascal, Luciana Tucunduva, Annalisa Ruggeri, Didier Blaise, Patrice Ceballos, Patrice Chevallier, Jan Cornelissen, Natacha Maillard, Reza Tabrizi, Eefke Petersen, Werner Linkesch, Henrik Sengeloev, Chantal Kenzey, Antonio Pagliuca, Ernst Holler, Hermann Einsele, Eliane Gluckman, Vanderson Rocha and Ibrahim Yakoub-Agha on behalf of Eurocord and the European Society for Blood and Marrow Transplantation
  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
    Stefan O. Ciurea, Mei-Jie Zhang, Andrea A. Bacigalupo, Asad Bashey, Frederick R. Appelbaum, Omar S. Aljitawi, Philippe Armand, Joseph H. Antin, Junfang Chen, Steven M. Devine, Daniel H. Fowler, Leo Luznik, Ryotaro Nakamura, Paul V. O’Donnell, Miguel-Angel Perales, Sai Ravi Pingali, David L. Porter, Marcie R. Riches, Olle T. H. Ringdén, Vanderson Rocha, Ravi Vij, Daniel J. Weisdorf, Richard E. Champlin, Mary M. Horowitz, Ephraim J. Fuchs and Mary Eapen

BLOOD WORK

CORRESPONDENCE

ERRATA

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS